MICHAEL KEHOE: Open Payments
NPI 1134487168 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,348 in 186 payments from 30 companies in 2025. Trend: 2023 $0 · 2024 $2,122 · 2025 $3,348
Food & beverage: $3,348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $814 |
| PFIZER INC. | 31 | $425 |
| Vanda Pharmaceuticals Inc. | 12 | $411 |
| Novo Nordisk Inc | 21 | $299 |
| AstraZeneca Pharmaceuticals LP | 12 | $263 |
| Corcept Therapeutics | 4 | $130 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| Lilly USA, LLC | 6 | $104 |
| Paratek Pharmaceuticals, Inc. | 2 | $80 |
| Lundbeck LLC | 3 | $70 |
Products named: QULIPTA, NURTEC ODT, FANAPT, VRAYLAR, Wegovy, UBRELVY, REXULTI, Korlym.
Industry payments across NC — which companies pay providers there.
